Loading, Please Wait...
DUBLIN, IRELAND --(Marketwired - February 10, 2016) - Research and Markets (http://www.researchandmarkets.com/research/wxfnk3/oncology_pathways) has announced the addition of the "Oncology Pathways in the US - Friend or Foe for Pharma?" report to their offering.
The costs of treating cancer in the US are spiralling upward, and payers have taken notice. This report takes a detailed look at the growing focus on value and quality that is driving greater use of clinical pathways. This great piece of analysis will allow you to formulate successful strategies that allow you to enter this market, taking all factors into consideration.
Key Topics Covered:
1. Executive Summary
2. Management of Oncology Costs
3. Oncology Clinical Pathway Programs and Developers
4. The Impact of Pathways on Oncology
5. Oncology Pathways and Pharma
6. Future of Oncology Pathways
For more information visit http://www.researchandmarkets.com/research/wxfnk3/oncology_pathways
Research and Markets
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716